Blog
Selank vs Semax: Comparing Two Neuropeptides in Research
Selank vs Semax is a comparison that comes up constantly in neuropeptide research. These are two of the best-known peptides to come out of Russian neuroscience, and they share a structural feature, but they were designed from different starting points and have been studied for different questions.
Key takeaways
- Semax is derived from ACTH(4-10); Selank is derived from tuftsin. Both carry a Pro-Gly-Pro tail.
- Semax research centers on neurotrophic signaling and neuroprotection models; Selank research centers on anxiety-related models and immune signaling.
- Neither is approved by the U.S. FDA, and much of the evidence comes from a small number of research groups.
Where each peptide comes from
Semax is a synthetic analog of a fragment of ACTH (adrenocorticotropic hormone), specifically the 4-10 region, with a Pro-Gly-Pro tail added to slow its breakdown. Its sequence is Met-Glu-His-Phe-Pro-Gly-Pro. It does not carry ACTH’s hormonal activity.
Selank is a synthetic analog of tuftsin, a naturally occurring tetrapeptide fragment of immunoglobulin G (Thr-Lys-Pro-Arg). It is extended with the same Pro-Gly-Pro tail to form Thr-Lys-Pro-Arg-Pro-Gly-Pro. Because tuftsin has immune-modulating roles, Selank has been studied at the border of immunology and neuroscience.
Selank vs Semax: what each has been studied for
| Semax | Selank | |
|---|---|---|
| Parent molecule | ACTH(4-10) | Tuftsin |
| Main research focus | Neuroprotection, cognition models, expression of neurotrophic factors such as BDNF | Anxiety-related models, stress response, immune signaling |
| Proposed mechanisms in the literature | Changes in BDNF and related gene expression, effects on dopaminergic and serotonergic signaling | Modulation of enkephalin breakdown, GABAergic signaling and cytokine expression |
| Origin of the work | Mostly Russian research groups | Mostly Russian research groups |
An honest note on the evidence
Both peptides have been used clinically in Russia, but neither is approved by the U.S. FDA. Much of the published work comes from a small number of research groups, often with small samples, and much of it is preclinical or published in regional journals. Independent replication in large, well-controlled trials is limited. Reviews of this literature should treat mechanisms as hypotheses and avoid extending them beyond what the studies measured. You can browse the papers yourself with a Selank and Semax search on PubMed.
Why the delivery route comes up
Both peptides are frequently studied as intranasal preparations, because nasal delivery is a route researchers use to look at how small peptides reach the central nervous system. How much actually does is a contested question. Our posts on Semax nasal absorption and on mucosal versus systemic pathways discuss the models and limits.
Choosing between Selank and Semax in study design
- If a question is about neurotrophic signaling or neuroprotection models, the Semax literature is larger.
- If the question involves anxiety-related behavior or neuro-immune interaction, Selank is the more commonly cited compound.
- If both are used, include controls for each peptide separately, since the shared Pro-Gly-Pro motif alone may contribute to observed effects.
Frequently asked questions
Do Selank and Semax have the same structure?
No. They share a Pro-Gly-Pro tail, but the sequences in front of it come from different parent molecules, ACTH(4-10) for Semax and tuftsin for Selank.
Are Selank and Semax FDA-approved?
No. Both have been used in clinical practice in Russia, but neither is approved by the U.S. FDA.
Why is the evidence considered limited?
Most studies come from a few research groups, with small samples and limited independent replication.
Quality and storage
Whichever compound is used, confirm identity and purity with a batch-specific certificate of analysis and store material as described in our guide to storing and handling research peptides.
All products are sold for laboratory research use only and are not intended for human consumption. This article is educational and does not constitute medical advice.